Related Experiment Video
Updated: Feb 10, 2026

Quantifying Vibrio cholerae Colonization and Diarrhea in the Adult Zebrafish Model
Published on: July 12, 2018
Pathophysiology of IBD associated diarrhea
Arivarasu N Anbazhagan1, Shubha Priyamvada1, Waddah A Alrefai1,2
1a Division of Gastroenterology and Hepatology, Department of Medicine, University of Illinois at Chicago , Chicago , IL , USA.
Inflammatory bowel diseases (IBD) cause chronic diarrhea due to impaired intestinal ion transport and barrier function. Understanding these mechanisms is key to managing this debilitating gastrointestinal condition.
Area of Science:
- Gastroenterology
- Immunology
- Microbiology
Background:
- Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), are chronic gastrointestinal disorders with rising global incidence.
- The complex etiology of IBD involves genetic, environmental, immunological, and gut microbial interactions.
- Recurring, bloody diarrhea is a primary and debilitating symptom of IBD.
Purpose of the Study:
- To review the mechanisms underlying impaired ion transport and epithelial barrier function in IBD-associated diarrhea.
- To elucidate how these factors contribute to the pathophysiology of diarrhea in inflammatory bowel diseases.
Main Methods:
- Review of existing literature on IBD pathogenesis, focusing on intestinal ion transport and epithelial barrier function.
- Analysis of molecular and cellular mechanisms contributing to diarrhea in CD and UC.
Main Results:
- Altered expression or function of epithelial ion transporters leads to electrolyte and water accumulation in the intestinal lumen.
- Impaired epithelial barrier function contributes to diarrhea through a leak-flux mechanism.
- Enteric pathogen penetration exacerbates dysbiosis and immune responses, perpetuating tissue damage and diarrhea.
Conclusions:
- Dysregulated intestinal ion transport is a principal driver of diarrhea in IBD.
- Loss of epithelial barrier integrity exacerbates diarrhea and disease progression.
- Targeting ion transport and barrier repair may offer therapeutic strategies for IBD-associated diarrhea.
Related Concept Videos
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Hypertension II: Pathophysiology
Pneumonia II: Pathophysiology
Drugs for Treatment of Ulcerative Colitis in IBD
Pathophysiology of Vomiting

